PTH and chronic kidney disease: PTH and FGF-23 are relevant compounds involved in the pathogenesis of CKD mineral and bone disorder (CKD-MBD) in children, influencing bone turnover, mineralization, volume, linear growth, structure and strength, as well as contributing to vascular calcification [82].